Terminology Service for NFDI4Health
All individuals in LOINC
| Label | Id | Description |
|---|---|---|
| Anti-DR9 (DRB1*09:01) | LA30731-6 | |
| Anti-E | LA19689-1 | |
| Anti-HPA-15a | LA32323-0 | |
| Anti-HPA-17b | LA32324-8 | |
| Anti-HPA-1a | LA32316-4 | |
| Anti-HPA-1b | LA32317-2 | |
| Anti-HPA-2a | LA32318-0 | |
| Anti-HPA-2b | LA32319-8 | |
| Anti-HPA-30b | LA32325-5 | |
| Anti-HPA-35b | LA32326-3 | |
| Anti-HPA-3a | LA32320-6 | |
| Anti-HPA-4b | LA32321-4 | |
| Anti-HPA-8b | LA32322-2 | |
| Anti-bipolar | LP31474-7 | |
| Anti-gastric acid secretion | LP31482-0 | |
| Anti-hyperglycemics | LP33333-3 | |
| Anti-hyperglycemics | MTHU016642 | |
| Anti-hyperglycemics | Serum or Plasma | Drug toxicology | LP388643-1 | |
| Anti-hyperglycemics:Prid:Pt:Ser/Plas:Nom:Screen | 35699-8 | |
| Anti-infection drugs | LP31450-7 |